Want to see IN:MUKKA full AI Analyst Report?
MUKKA Stock Chart & Stats
₹22.65
₹0.29(1.28%)
At close: 4:00 PM EDT
₹22.65
₹0.29(1.28%)
Day’s Range― - ―
52-Week Range₹18.32 - ₹31.20
Previous CloseN/A
Volume131.60K
Average Volume (3M)40.24K
Market Cap
₹7.96B
Enterprise Value₹13.09K
Total Cash (Recent Filing)₹604.29M
Total Debt (Recent Filing)₹7.79B
Price to Earnings (P/E)11.2
Beta0.71
Next Earnings
Nov 12, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.73
Shares Outstanding300,000,000
10 Day Avg. Volume18,929
30 Day Avg. Volume40,240
Financial Highlights & Ratios
PEG Ratio0.87
Price to Book (P/B)1.11
Price to Sales (P/S)0.38
P/FCF Ratio-1.86
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Strong Revenue GrowthStrong multi-year revenue expansion indicates increasing scale and demand for the company’s marine protein products. Sustained top-line growth can improve operating leverage and strengthen its position with feed manufacturers and bulk buyers.
Consistent Reported ProfitabilityConsistent reported profits show that Mukka Proteins has remained economically viable while expanding. Although margins are modest, repeated profitability provides a foundation for reinvestment and suggests the core processing model can generate accounting earnings.
Diversified Feed ApplicationsServing multiple animal nutrition end markets reduces dependence on a single application and broadens the addressable customer base. Demand across aquaculture, poultry, and pet or animal feed supports longer-term relevance for its marine ingredient portfolio.
Bears Say
Persistently Negative Cash FlowPersistent operating and free cash flow deficits indicate that reported growth is not translating into internal funding. Continued expansion may therefore require borrowing or equity, increasing financing dependence and weakening the durability of earnings.
Rising Debt BurdenThe sharp increase in debt raises balance-sheet risk, particularly alongside negative cash generation. Higher leverage can constrain financial flexibility, increase funding needs, and make future expansion more vulnerable to weaker operating conditions.
Modest And Pressured MarginsLow margins leave limited protection against changes in fish supply, processing yields, and commodity pricing. The 2026 slowdown in profit growth and prior revenue decline indicate that expansion may not consistently convert into stronger profitability.
Mukka Proteins Limited News
MUKKA FAQ
What was Mukka Proteins Limited’s price range in the past 12 months?
Mukka Proteins Limited lowest stock price was ₹18.32 and its highest was ₹31.20 in the past 12 months.
What is Mukka Proteins Limited’s market cap?
Mukka Proteins Limited’s market cap is ₹7.96B.
When is Mukka Proteins Limited’s upcoming earnings report date?
Mukka Proteins Limited’s upcoming earnings report date is Nov 12, 2026 which is in 78 days.
How were Mukka Proteins Limited’s earnings last quarter?
Mukka Proteins Limited released its earnings results on Aug 12, 2026. The company reported ₹0.63 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Mukka Proteins Limited overvalued?
According to Wall Street analysts Mukka Proteins Limited’s price is currently Overvalued.
Does Mukka Proteins Limited pay dividends?
Mukka Proteins Limited does not currently pay dividends.
What is Mukka Proteins Limited’s EPS estimate?
Mukka Proteins Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Mukka Proteins Limited have?
Mukka Proteins Limited has 300,000,000 shares outstanding.
What happened to Mukka Proteins Limited’s price movement after its last earnings report?
Mukka Proteins Limited reported an EPS of ₹0.63 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.555%.
Which hedge fund is a major shareholder of Mukka Proteins Limited?
Currently, no hedge funds are holding shares in IN:MUKKA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Mukka Proteins Limited
Mukka Proteins Limited, based in Mangaluru, India, operates as a prominent manufacturer and supplier of protein products, extending its reach both domestically and internationally. The company specializes in a variety of fish-derived offerings, including fish meal, fish oil, and soluble fish paste. Expanding its portfolio, it also produces insect meal and insect oil. These versatile ingredients serve a wide range of industrial applications, notably in enhancing animal, poultry, and aquaculture feeds, and are furthermore utilized in pharmaceutical goods, soap production, leather tanneries, and paint manufacturing. The firm maintains a robust global presence, exporting its products to numerous countries across Asia and beyond, such as Bahrain, China, South Korea, and Vietnam, among others. Established in 1960, the company officially rebranded in August 2021, transitioning from its former identity, Mukka Sea Food Industries Limited, to its current name, Mukka Proteins Limited.
Technical Analysis
Avanti Feeds Limited
―
Hatsun Agro Product Limited
―
M K Proteins Limited
―
Parag Milk Foods Ltd.
―
SKM Egg Products Export (India) Ltd.
―